CRL vs LNTH: fair value comparison
Charles River Laboratories International, Inc. and Lantheus Holdings, Inc. · Updated 2026-08-31
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, LNTH currently sits closer to the top of our discount ranking. LNTH carries the stronger quality grade.
| CRL | LNTH | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $291.50 | $101.19 |
| 12-month range | $161.25–$232.51 | $51.63–$108.96 |
| Sector rank | #103 of 113 Healthcare | #102 of 113 Healthcare |
| Quality grade | C | A |
| Momentum grade | — | A |
| Leverage | Moderate | Moderate |
| Margin trend | Contracting | Contracting |
| Revenue growth | Modest | Strong |
| RSI zone | Overbought | Neutral |
| 50/200-day trend | — | Mixed |
| DCF cross-check | Overvalued | Fairly Valued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: CRL fair value analysis · LNTH fair value analysis